News | November 05, 2010

Research Grants Awarded to Stereotaxis

November 5, 2010 – Stereotaxis has been awarded $1.5 million in grants under the Qualifying Therapeutic Discovery Project Program. Enacted under the Patient Protection and Affordable Care Act of 2010, the program targets projects that address unmet needs, reduce long-term healthcare costs and produce new therapies.

The company was awarded grants for projects related to its Niobe remote magnetic navigation system and the Odyssey system, which treat heart arrhythmias using magnetic catheters.

"We are pleased that the U.S. Department of Health and Human Services recognizes the potential impact that Stereotaxis' innovative technologies can have for patients suffering from diseases of the heart," said Michael P. Kaminski, president and CEO of Stereotaxis. "These grants will allow Stereotaxis to further enhance and expand the capabilities of our technology in an effort to treat the most common type of heart arrhythmias, atrial fibrillation, as well as ventricular tachycardia and other cardiovascular disorders."

For more information: www.stereotaxis.com

Related Content

Transesophageal Echo, TEE. Interventional echocardiography, interventional echo, Philips, CX50

Transesophageal echo (TEE) has become an essential part of the new transcatheter structrual heart therapies, giving rise to a new sub-speciality of interventional echocardiography.  

Feature | Cath Lab Navigation Aids| September 21, 2016 | Dave Fornell
The rapid growth of transcatheter structural heart procedures and the need for increased use of echocardiography as a
News | Cath Lab Navigation Aids| January 15, 2016
Teleflex Inc. has acquired privately held Nostix LLC, developer of innovative tip confirmation systems that are used to...
vessel assist, CTO fusion imaging

An example of Vessel Assist used to create vessel centerlines through a CTO to help guide revascularization in the cath lab.

Technology | Cath Lab Navigation Aids| December 14, 2015
December 14, 2015 — As the field of interventional medicine grows, so do the challenges for clinicians to plan, guide
Overlay Init